Novo Nordisk received approval for Wegovy tablets in December 2025
"Theyre still looking at the science, Kennedy said
Within Medicaid in most states, beneficiaries may have to choose a managed care planeach with a different formulary
These data indicated that GLP-1R overexpression reduces cell proliferation and migration, and therefore may serve a role in airway remodeling in COPD patients
Individuals experience increased energy, pain decreases, and daily life becomes more manageable
Summary: GLP-1 receptor agonists do not directly cause sweating, but some patients report changes in perspiration patterns due to indirect factors such as gastrointestinal side effects, hypoglycaemia when combined with other diabetes medications, or autonomic responses to nausea